Le Lézard
Classified in: Health
Subjects: SVY, POL, PSF, STP

Representative Bahr Lauds the Accomplishments of NPLEx in the First Quarter of 2015



JEFFERSON CITY, Mo., June 29, 2015 /PRNewswire/ -- Missouri State Representative Kurt Bahr (R-O'Fallon) today released the 2015 first quarter data from the state's real-time, stop-sale system, known as the National Precursor Log Exchange (NPLEx).

States across the United States are using NPLEx, making Missouri one of 31 across the country that currently utilize the system to automatically block unlawful, attempted pseudoephedrine (PSE) purchases at the point of sale.  NPLEx aids retailers and law enforcement officers as they work together to seek to stop criminals from purchasing medicine containing PSE and attempt to divert the decongestant to meth. NPLEx has played a vital role across the country limiting the illegal sale of PSE and stopping domestic meth production.

During the first quarter of 2015, the NPLEx system in Missouri helped block the sale of 4,390 boxes of PSE, keeping 11,401 grams from being used illegally.

"In the first quarter of 2015, NPLEx again proved that it is an important tool for law officers in their fight against meth," said Representative Bahr. "Our state has seen a decline in domestic meth production in recent years as meth criminals find it harder to make the drug. This does not mean the fight is over. Missouri must fight the increasing amount of meth coming in from Mexico as drug cartels replace what previously had been domestically produced. I have no doubt that our state will stand up to this drug and continue to make sure our addicts our treated, while maintaining law-abiding citizens' access to cold and allergy medications containing PSE."

SOURCE Missouri State Representative Kurt Bahr


These press releases may also interest you

24 fév 2018
Experts in pediatric heart disease from multiple centers worldwide are sharing their findings at a large national conference sponsored by the Cardiac Center at Children's Hospital of Philadelphia (CHOP). Cardiology 2018, the 21th Annual Update on...

24 fév 2018
Terumo BCT announced today that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.S.-based software developer. StafaCT software supports healthcare facilities and cell labs as they manage each phase of the cellular...

24 fév 2018
JUUL Labs, Inc. today announced results from a preliminary study on the temperature regulation and harmful and potentially harmful constituents (HPHCs) of JUUL's Virginia Tobacco 5% nicotine-e-liquid filled pod. The findings, "Characterization of...

24 fév 2018
A new study reveals that most adults hold beliefs about the harms from nicotine that are opposite from what scientists have concluded. The findings, presented at the Society for Research on Nicotine and Tobacco 24th Annual Meeting in Baltimore,...

24 fév 2018
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that it has filed a class action against MiMedx Group, Inc. ("MiMedx" or the "Company") and certain of its officers for violations of...

24 fév 2018
SAN RAFAEL, Calif., Feb. 24, 2018 /PRNewswire-PRWeb/ -- Michael Moskowitz, MD, MPH and Randy Perretta of Anandamedicine, Bill Heriot of Liposome Formulations Inc, George Bianchini of Medi-Cone and Leonard Leinow of Synergy Wellness have joined to...




News published on 29 june 2015 at 12:30 and distributed by: